Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Cabana vs FMmeds

Cabana
Graded #411

Lower grade

vs+6.700000000000003
FMmeds
Graded #257

Higher grade

The verdict

FMmeds takes it — 63.2/100 to 56.5/100.

FMmeds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. FMmeds is a Manhattan Beach-based DTC telehealth platform selling compounded semaglutide and tirzepatide co-formulated with vitamin B12, with no membership fee and a free initial visit billed only on approval.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueFMmeds +1
45
46
Dose & formulationFMmeds +8
64
72
Clinical oversightCabana +6
76
70
Labs & monitoringFMmeds +1
52
53
FulfillmentFMmeds +32
65
97
Contract termsFMmeds +27
20
47
Cabana · left barFMmeds · right bar

The numbers

MetricCabanaFMmeds
WeighScore56.5/10063.2/100
GradeCC
Scorecard rank#411#257
SemaglutideNot disclosed$225/mo (all doses, compounded)
TirzepatideNot disclosed$265/mo (all doses, compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
Cabana

Graded #411 · C

Strengths

  • Compounded semaglutide (injection + oral tablet) and tirzepatide injection
  • Membership includes the prescription, provider care, and free shipping — no insurance needed
  • Concierge support model with a dedicated point of contact
  • Async online assessment with licensed-provider review and fast approval

Where it loses points

  • Pricing is not disclosed publicly — only shown after the online assessment
  • Membership fee is non-refundable once paid
  • Compounding pharmacy is not publicly named
FMmeds

Graded #257 · C

Strengths

  • All 50 states plus DC covered, stated in the Terms
  • Operating LLC and full Manhattan Beach, CA address disclosed
  • Named 503A pharmacy partner (Manifest Pharmacy, Greer SC)
  • Aggressive 12-month pricing — semaglutide $95/mo and tirzepatide $145/mo, at the low end of the market
  • Flat pricing across all dose strengths — no dose-escalation surcharge

Where it loses points

  • Compounded only — no FDA-approved Wegovy, Ozempic, Mounjaro, or Zepbound
  • Publishes the FDA compounded-medication disclaimer (medication is not FDA-approved)
  • Clinical network not separately named
  • LegitScript Certified, but the specific ID isn't shown
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard